$234.030
+9.970 (+4.26%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ALNY Prediction & Forecast by Similar Chart Analysis
Alphio's ALNY stock price prediction model matches the current Alnylam Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $234.40 (+0.16%). The 1-week path is $233.40 (-0.27%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Alnylam Pharmaceuticals, Inc. Stock?
Alnylam Pharmaceuticals is a good buy right now due to its recent revenue surge of 74% year-over-year, bringing in $1.17 billion in the latest quarter, and a positive analyst sentiment with 18 out of 21 analysts recommending a buy. The current price of $232.68 is significantly lower than the average analyst price target of $336, suggesting a potential upside of approximately 44%. However, the main risk is the company's high debt-to-equity ratio of 201.69%, which could impact financial stability if not managed carefully.
ALNY stock price ended at $234.03 on Thursday, after rising +4.26%
Alnylam Pharmaceuticals, Inc. (ALNY) last closed at $234.03, gaining +4.26%. These facts feed the 1-day and 1-week ALNY price prediction above.
Analyst Consensus
Alnylam Pharmaceuticals, Inc. (ALNY): 13 buy, 4 hold, 1 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Alnylam Pharmaceuticals, Inc. (ALNY) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ALNY, ranked by similarity.
Seasonality analysis for ALNY
Historically the probability of a positive October return for ALNY is 79.31%. November offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ALNY
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $350.62 | $412.92 | $470.51 | +76.44% |
| Nov 2026 | $361.56 | $412.92 | $530.74 | +76.44% |
| Dec 2026 | $182.69 | $289.06 | $422.33 | +23.51% |
In 2026, Alnylam Pharmaceuticals, Inc. (ALNY) is projected to range from $182.69 to $530.74.
Alnylam Pharmaceuticals, Inc. 2026 monthly forecast
In Oct 2026, Alnylam Pharmaceuticals, Inc. is projected to average $412.92, with a low of $350.62 and high of $470.51.
In Nov 2026, Alnylam Pharmaceuticals, Inc. is projected to average $412.92, with a low of $361.56 and high of $530.74.
In Dec 2026, Alnylam Pharmaceuticals, Inc. is projected to average $289.06, with a low of $182.69 and high of $422.33.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.